Acurx Pharmaceuticals Inc.
ACXP | NASDAQ
$1.33
-$0.06 (-4.32%)
At close: Sep 21, 2026, 4:00 PM ET
$1.31
-$0.02 (-1.50%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $5.97M
Enterprise Value $-4.94M
Beta -2.02
Average Volume 119.79K
Shares Outstanding (Diluted) 4.26M
Shares Change YoY 257.86%
Institutional Ownership 12.22%
Exchange NASDAQ
ISIN US00510M2035
Price Performance
Price Change 1M -9.5%
Price Change 3M -6.3%
Price Change 6M -68.8%
Price Change YTD -51.8%
Price Change 1Y -67.4%
Price Change 3Y -95.7%
Price Change 5Y -98.5%
1M CAGR (ann.) -4.8%
1Y CAGR (ann.) -66.3%
5Y CAGR (ann.) -57.5%
All-Time CAGR -59.5%
Valuation
PE Ratio -0.37
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.03
PS Ratio N/A
Forward PS 1.60
PB Ratio 0.70
P/FCF Ratio -0.00
P/Adj. FCF Ratio -0.00
P/OCF Ratio -0.92
EV/Sales N/A
EV/EBIT 0.65
EV/EBITDA 0.65
EV/FCF 0.00
Earnings Yield -266.9%
FCF Yield -29993.5%
Adj. FCF Yield -33514.3%
Financial Health
Net Cash $10.66M
Total Debt $0
Cash & Short-Term Investments $10.66M
Total Assets $10.98M
Current Ratio 3.88
Quick Ratio 3.88
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -10.21
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -11.7%
Returns
Return on Assets -68.3%
Return on Equity -124.7%
Return on Invested Capital -94.1%
Return on Capital Employed -94.1%
Return on Tangible Assets -68.3%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 78.7%
EPS CAGR 5Y 33.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y -147.2%
FCF CAGR 5Y -97.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 17.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.45
EPS Growth Est (next Q) -63.4%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $31
Price Target Upside 2230.8%
Cash Flow
Operating Cash Flow $-1.71B
Free Cash Flow $-1.71B
Adj. Free Cash Flow $-1.92B
FCF Per Share -$1.45
OCF Per Share -$1.45
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-7.67M
EBITDA $-7.56M
Net Income $-7.51M
EPS (Diluted) -$3.55
Revenue / Employee N/A
Profit / Employee $-1.88M
Employees 4
Add to Watchlist
Select watchlists to add or remove ACXP